Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients With HER2+ Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-positive Breast Cancer
Sponsor: Daiichi Sankyo France